Welcome to Beijing Wantai

This is Wantai

Founded in 1991 and developed from a small laboratory, Beijing Wantai Biological Pharmacy is one of the largest Chinese manufacturer of in vitro diagnostic test. Wantai is located at Zhongguancun Life Science Park - the biotechnology heart of Beijing. Wantai is a private company which belongs to Yangshengtang Group.

We operate and maintain domestic and international diagnostic reagents business with ELISA kits and rapid test for clinical diagnosis of human infectious diseases and for screening of blood donors. Our main customers are blood banks, hospitals and clinics, reference laboratories, border inspection centres, blood-processing companies and research institutes.

Markets: Wantai is the largest supplier of HIV and HCV ELISA in China.

In China, Wantai has over 350 clients within the blood banking market sector. 3000 hospital are also clients of Wantai. The company has developed and currently maintains the largest sales network for supply of blood screening reagents in China. Our sales force is over 100 people and we have established business relations with more than 200 diagnostic distributor companies in China.

Company structure

There are four different companies which form Wantai Corporation, three of which are located in Beijing and one in Xiamen:

- Wantai - the core company which produces ELISA and rapid tests for infectious diseases

- DRD Co.Ltd- company which specializes in manufacturing and distribution of routine clinical chemistry reagents

- Beijing Control & Standard Co. Ltd - company which specializes in the research development and manufacturing of quality control substances and references sera

- Wantai Xiamen - company which specializes in the research, development and commercialization of recombinant vaccines

Over 400 people work for Wantai. Our facility in Beijing, fully certified GMP/ISO13485 plan, is the largest manufacturing base for production of infectious diseases diagnostics in China.

Partners

Wantai has recognized the need to establish domestic and international partnerships network as an indispensable approach in achieving successes in the highly competitive market for diagnostics and vaccines.

The company maintains strategic partnerships with both scientific and business institutions in China and internationally. Such collaborative approach provides the company with strong technology platform in research and development, and with the knowledge Wantai needs for continuously upgrade of its product pipeline by applying the latest achievements of science and technology.

Our key partners include Xiamen University, Hong Kong University and the French companies BIO-RAD and DIAGAST.

Download company's presentation